nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CRABP1—embryo—polycystic ovary syndrome	0.0145	0.0497	CbGeAlD
Alitretinoin—Vitamin A—RBP4—polycystic ovary syndrome	0.0138	0.786	CrCbGaD
Alitretinoin—CRABP2—embryo—polycystic ovary syndrome	0.0132	0.045	CbGeAlD
Alitretinoin—CYP1A2—urine—polycystic ovary syndrome	0.0104	0.0354	CbGeAlD
Alitretinoin—Emotional distress—Metformin—polycystic ovary syndrome	0.00967	0.0503	CcSEcCtD
Alitretinoin—CRABP1—pituitary gland—polycystic ovary syndrome	0.00963	0.0329	CbGeAlD
Alitretinoin—CRABP2—endometrium—polycystic ovary syndrome	0.00963	0.0329	CbGeAlD
Alitretinoin—CRABP2—pituitary gland—polycystic ovary syndrome	0.00871	0.0298	CbGeAlD
Alitretinoin—CRABP2—adipose tissue—polycystic ovary syndrome	0.00868	0.0297	CbGeAlD
Alitretinoin—CRABP1—vagina—polycystic ovary syndrome	0.00798	0.0273	CbGeAlD
Alitretinoin—CRABP2—adrenal gland—polycystic ovary syndrome	0.00778	0.0266	CbGeAlD
Alitretinoin—RXRG—pituitary gland—polycystic ovary syndrome	0.00762	0.026	CbGeAlD
Alitretinoin—RXRG—adipose tissue—polycystic ovary syndrome	0.00758	0.0259	CbGeAlD
Alitretinoin—CRABP1—endocrine gland—polycystic ovary syndrome	0.00746	0.0255	CbGeAlD
Alitretinoin—Acidosis—Metformin—polycystic ovary syndrome	0.00743	0.0386	CcSEcCtD
Alitretinoin—Body temperature decreased—Metformin—polycystic ovary syndrome	0.00734	0.0381	CcSEcCtD
Alitretinoin—Hypothermia—Metformin—polycystic ovary syndrome	0.00734	0.0381	CcSEcCtD
Alitretinoin—CRABP2—female gonad—polycystic ovary syndrome	0.00726	0.0248	CbGeAlD
Alitretinoin—RXRA—female gonad—polycystic ovary syndrome	0.00723	0.0247	CbGeAlD
Alitretinoin—CRABP2—vagina—polycystic ovary syndrome	0.00721	0.0246	CbGeAlD
Alitretinoin—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00699	0.0363	CcSEcCtD
Alitretinoin—RARB—adrenal gland—polycystic ovary syndrome	0.00696	0.0238	CbGeAlD
Alitretinoin—RXRG—adrenal gland—polycystic ovary syndrome	0.0068	0.0232	CbGeAlD
Alitretinoin—CRABP2—endocrine gland—polycystic ovary syndrome	0.00675	0.0231	CbGeAlD
Alitretinoin—RXRA—endocrine gland—polycystic ovary syndrome	0.00672	0.023	CbGeAlD
Alitretinoin—RARA—endometrium—polycystic ovary syndrome	0.0066	0.0226	CbGeAlD
Alitretinoin—RARB—female gonad—polycystic ovary syndrome	0.00649	0.0222	CbGeAlD
Alitretinoin—Respiratory distress—Metformin—polycystic ovary syndrome	0.00647	0.0336	CcSEcCtD
Alitretinoin—RARG—uterus—polycystic ovary syndrome	0.00647	0.0221	CbGeAlD
Alitretinoin—RARB—vagina—polycystic ovary syndrome	0.00645	0.022	CbGeAlD
Alitretinoin—RXRB—adrenal gland—polycystic ovary syndrome	0.0064	0.0219	CbGeAlD
Alitretinoin—Nail disorder—Metformin—polycystic ovary syndrome	0.00634	0.033	CcSEcCtD
Alitretinoin—RARG—adipose tissue—polycystic ovary syndrome	0.00633	0.0216	CbGeAlD
Alitretinoin—Upset stomach—Metformin—polycystic ovary syndrome	0.00628	0.0326	CcSEcCtD
Alitretinoin—RARA—uterus—polycystic ovary syndrome	0.00609	0.0208	CbGeAlD
Alitretinoin—RARB—endocrine gland—polycystic ovary syndrome	0.00604	0.0206	CbGeAlD
Alitretinoin—RARA—pituitary gland—polycystic ovary syndrome	0.00598	0.0204	CbGeAlD
Alitretinoin—RXRB—female gonad—polycystic ovary syndrome	0.00596	0.0204	CbGeAlD
Alitretinoin—RARA—adipose tissue—polycystic ovary syndrome	0.00595	0.0203	CbGeAlD
Alitretinoin—RXRB—vagina—polycystic ovary syndrome	0.00593	0.0203	CbGeAlD
Alitretinoin—RXRG—endocrine gland—polycystic ovary syndrome	0.0059	0.0202	CbGeAlD
Alitretinoin—RARG—adrenal gland—polycystic ovary syndrome	0.00568	0.0194	CbGeAlD
Alitretinoin—RXRB—endocrine gland—polycystic ovary syndrome	0.00555	0.019	CbGeAlD
Alitretinoin—RARA—adrenal gland—polycystic ovary syndrome	0.00534	0.0182	CbGeAlD
Alitretinoin—RARG—female gonad—polycystic ovary syndrome	0.00529	0.0181	CbGeAlD
Alitretinoin—RARG—vagina—polycystic ovary syndrome	0.00526	0.018	CbGeAlD
Alitretinoin—RARA—female gonad—polycystic ovary syndrome	0.00498	0.017	CbGeAlD
Alitretinoin—Contusion—Metformin—polycystic ovary syndrome	0.00471	0.0245	CcSEcCtD
Alitretinoin—Chest discomfort—Metformin—polycystic ovary syndrome	0.00465	0.0242	CcSEcCtD
Alitretinoin—RARA—endocrine gland—polycystic ovary syndrome	0.00463	0.0158	CbGeAlD
Alitretinoin—Lightheadedness—Metformin—polycystic ovary syndrome	0.00368	0.0191	CcSEcCtD
Alitretinoin—Ear pain—Metformin—polycystic ovary syndrome	0.0035	0.0182	CcSEcCtD
Alitretinoin—Nasal congestion—Metformin—polycystic ovary syndrome	0.00328	0.017	CcSEcCtD
Alitretinoin—Renal impairment—Metformin—polycystic ovary syndrome	0.00314	0.0163	CcSEcCtD
Alitretinoin—Lethargy—Metformin—polycystic ovary syndrome	0.00305	0.0158	CcSEcCtD
Alitretinoin—Pain in extremity—Metformin—polycystic ovary syndrome	0.00299	0.0155	CcSEcCtD
Alitretinoin—Dehydration—Metformin—polycystic ovary syndrome	0.00278	0.0144	CcSEcCtD
Alitretinoin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00267	0.0139	CcSEcCtD
Alitretinoin—Abdominal distension—Metformin—polycystic ovary syndrome	0.0026	0.0135	CcSEcCtD
Alitretinoin—Pancreatitis—Metformin—polycystic ovary syndrome	0.00253	0.0131	CcSEcCtD
Alitretinoin—Sweating increased—Metformin—polycystic ovary syndrome	0.00251	0.0131	CcSEcCtD
Alitretinoin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00247	0.0129	CcSEcCtD
Alitretinoin—Neutropenia—Metformin—polycystic ovary syndrome	0.00241	0.0125	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0024	0.0125	CcSEcCtD
Alitretinoin—Infestation NOS—Metformin—polycystic ovary syndrome	0.0023	0.012	CcSEcCtD
Alitretinoin—Infestation—Metformin—polycystic ovary syndrome	0.0023	0.012	CcSEcCtD
Alitretinoin—Drowsiness—Metformin—polycystic ovary syndrome	0.0023	0.012	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00225	0.0117	CcSEcCtD
Alitretinoin—Hepatitis—Metformin—polycystic ovary syndrome	0.00207	0.0107	CcSEcCtD
Alitretinoin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00205	0.0107	CcSEcCtD
Alitretinoin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00203	0.0106	CcSEcCtD
Alitretinoin—Eye disorder—Metformin—polycystic ovary syndrome	0.00193	0.01	CcSEcCtD
Alitretinoin—Vitamin A—CYP1A1—polycystic ovary syndrome	0.00192	0.109	CrCbGaD
Alitretinoin—Flushing—Metformin—polycystic ovary syndrome	0.00192	0.00996	CcSEcCtD
Alitretinoin—Angiopathy—Metformin—polycystic ovary syndrome	0.00187	0.00974	CcSEcCtD
Alitretinoin—Chills—Metformin—polycystic ovary syndrome	0.00185	0.00963	CcSEcCtD
Alitretinoin—Tretinoin—CYP1A1—polycystic ovary syndrome	0.00185	0.105	CrCbGaD
Alitretinoin—Erythema—Metformin—polycystic ovary syndrome	0.0018	0.00934	CcSEcCtD
Alitretinoin—Malnutrition—Metformin—polycystic ovary syndrome	0.0018	0.00934	CcSEcCtD
Alitretinoin—Flatulence—Metformin—polycystic ovary syndrome	0.00177	0.00921	CcSEcCtD
Alitretinoin—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00172	0.00586	CbGeAlD
Alitretinoin—ABCB1—embryo—polycystic ovary syndrome	0.00171	0.00586	CbGeAlD
Alitretinoin—Vision blurred—Metformin—polycystic ovary syndrome	0.00169	0.00881	CcSEcCtD
Alitretinoin—Tremor—Metformin—polycystic ovary syndrome	0.00168	0.00875	CcSEcCtD
Alitretinoin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00167	0.00867	CcSEcCtD
Alitretinoin—Malaise—Metformin—polycystic ovary syndrome	0.00162	0.00843	CcSEcCtD
Alitretinoin—Syncope—Metformin—polycystic ovary syndrome	0.00161	0.00838	CcSEcCtD
Alitretinoin—Palpitations—Metformin—polycystic ovary syndrome	0.00159	0.00826	CcSEcCtD
Alitretinoin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00158	0.00821	CcSEcCtD
Alitretinoin—Hypertension—Metformin—polycystic ovary syndrome	0.00155	0.00807	CcSEcCtD
Alitretinoin—Chest pain—Metformin—polycystic ovary syndrome	0.00153	0.00795	CcSEcCtD
Alitretinoin—Myalgia—Metformin—polycystic ovary syndrome	0.00153	0.00795	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00152	0.0079	CcSEcCtD
Alitretinoin—Discomfort—Metformin—polycystic ovary syndrome	0.00151	0.00786	CcSEcCtD
Alitretinoin—Oedema—Metformin—polycystic ovary syndrome	0.00147	0.00763	CcSEcCtD
Alitretinoin—Infection—Metformin—polycystic ovary syndrome	0.00146	0.00758	CcSEcCtD
Alitretinoin—Shock—Metformin—polycystic ovary syndrome	0.00144	0.0075	CcSEcCtD
Alitretinoin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00144	0.00748	CcSEcCtD
Alitretinoin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00144	0.00747	CcSEcCtD
Alitretinoin—Skin disorder—Metformin—polycystic ovary syndrome	0.00143	0.00741	CcSEcCtD
Alitretinoin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00142	0.00737	CcSEcCtD
Alitretinoin—ABCB1—adrenal cortex—polycystic ovary syndrome	0.0014	0.0048	CbGeAlD
Alitretinoin—Anorexia—Metformin—polycystic ovary syndrome	0.0014	0.00727	CcSEcCtD
Alitretinoin—Hypotension—Metformin—polycystic ovary syndrome	0.00137	0.00713	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00134	0.00695	CcSEcCtD
Alitretinoin—Paraesthesia—Metformin—polycystic ovary syndrome	0.00132	0.00685	CcSEcCtD
Alitretinoin—Dyspnoea—Metformin—polycystic ovary syndrome	0.00131	0.0068	CcSEcCtD
Alitretinoin—Somnolence—Metformin—polycystic ovary syndrome	0.0013	0.00678	CcSEcCtD
Alitretinoin—Dyspepsia—Metformin—polycystic ovary syndrome	0.00129	0.00671	CcSEcCtD
Alitretinoin—Decreased appetite—Metformin—polycystic ovary syndrome	0.00128	0.00663	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00127	0.00658	CcSEcCtD
Alitretinoin—Fatigue—Metformin—polycystic ovary syndrome	0.00126	0.00657	CcSEcCtD
Alitretinoin—Constipation—Metformin—polycystic ovary syndrome	0.00125	0.00652	CcSEcCtD
Alitretinoin—ABCB1—endometrium—polycystic ovary syndrome	0.00125	0.00429	CbGeAlD
Alitretinoin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00121	0.00628	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0012	0.00624	CcSEcCtD
Alitretinoin—Urticaria—Metformin—polycystic ovary syndrome	0.00117	0.00606	CcSEcCtD
Alitretinoin—Abdominal pain—Metformin—polycystic ovary syndrome	0.00116	0.00603	CcSEcCtD
Alitretinoin—ABCB1—uterus—polycystic ovary syndrome	0.00116	0.00395	CbGeAlD
Alitretinoin—ABCB1—pituitary gland—polycystic ovary syndrome	0.00114	0.00388	CbGeAlD
Alitretinoin—ABCB1—adipose tissue—polycystic ovary syndrome	0.00113	0.00386	CbGeAlD
Alitretinoin—Asthenia—Metformin—polycystic ovary syndrome	0.00105	0.00547	CcSEcCtD
Alitretinoin—Pruritus—Metformin—polycystic ovary syndrome	0.00104	0.00539	CcSEcCtD
Alitretinoin—ABCB1—adrenal gland—polycystic ovary syndrome	0.00101	0.00347	CbGeAlD
Alitretinoin—Diarrhoea—Metformin—polycystic ovary syndrome	0.001	0.00522	CcSEcCtD
Alitretinoin—Dizziness—Metformin—polycystic ovary syndrome	0.00097	0.00504	CcSEcCtD
Alitretinoin—ABCB1—female gonad—polycystic ovary syndrome	0.000946	0.00323	CbGeAlD
Alitretinoin—ABCB1—vagina—polycystic ovary syndrome	0.00094	0.00321	CbGeAlD
Alitretinoin—Vomiting—Metformin—polycystic ovary syndrome	0.000933	0.00485	CcSEcCtD
Alitretinoin—Rash—Metformin—polycystic ovary syndrome	0.000925	0.00481	CcSEcCtD
Alitretinoin—Dermatitis—Metformin—polycystic ovary syndrome	0.000924	0.0048	CcSEcCtD
Alitretinoin—Headache—Metformin—polycystic ovary syndrome	0.000919	0.00478	CcSEcCtD
Alitretinoin—ABCB1—endocrine gland—polycystic ovary syndrome	0.000879	0.00301	CbGeAlD
Alitretinoin—Nausea—Metformin—polycystic ovary syndrome	0.000871	0.00453	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.000213	0.000429	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—POMC—polycystic ovary syndrome	0.000213	0.000429	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000213	0.000429	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000213	0.000429	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000213	0.000428	CbGpPWpGaD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000212	0.000426	CbGpPWpGaD
Alitretinoin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000209	0.00042	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000209	0.00042	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	0.000208	0.000419	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000203	0.000408	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000202	0.000405	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000201	0.000405	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP19A1—polycystic ovary syndrome	0.0002	0.000403	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP19A1—polycystic ovary syndrome	0.0002	0.000403	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PGR—polycystic ovary syndrome	0.000199	0.0004	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000199	0.000399	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000198	0.000397	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000197	0.000397	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PGR—polycystic ovary syndrome	0.000195	0.000393	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000195	0.000392	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000189	0.000381	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000189	0.000381	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000189	0.00038	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000189	0.00038	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000189	0.000379	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PGR—polycystic ovary syndrome	0.000187	0.000377	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PGR—polycystic ovary syndrome	0.000187	0.000377	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000186	0.000374	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000185	0.000372	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKR1C2—polycystic ovary syndrome	0.000182	0.000366	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TEAD2—polycystic ovary syndrome	0.000182	0.000366	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000182	0.000365	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GNAS—polycystic ovary syndrome	0.000179	0.00036	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GNAS—polycystic ovary syndrome	0.000179	0.00036	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000178	0.000358	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000175	0.000352	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000174	0.000349	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—DLG4—polycystic ovary syndrome	0.000173	0.000348	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000172	0.000346	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000172	0.000345	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000172	0.000345	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000172	0.000345	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000171	0.000344	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000171	0.000343	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000171	0.000343	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NCOR1—polycystic ovary syndrome	0.00017	0.000343	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NCOR1—polycystic ovary syndrome	0.00017	0.000343	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AR—polycystic ovary syndrome	0.000169	0.000341	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.000167	0.000337	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—RPL37A—polycystic ovary syndrome	0.000167	0.000335	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000165	0.000331	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000165	0.000331	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000163	0.000328	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000162	0.000326	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000162	0.000326	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000162	0.000325	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000162	0.000325	CbGpPWpGaD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000158	0.000318	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000158	0.000317	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000155	0.000312	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AR—polycystic ovary syndrome	0.000155	0.000311	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000154	0.000309	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PNPLA2—polycystic ovary syndrome	0.000152	0.000306	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AR—polycystic ovary syndrome	0.000152	0.000305	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000152	0.000305	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000151	0.000303	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—MTHFR—polycystic ovary syndrome	0.000151	0.000303	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—MTHFR—polycystic ovary syndrome	0.000151	0.000303	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NCOR1—polycystic ovary syndrome	0.000148	0.000298	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AR—polycystic ovary syndrome	0.000146	0.000293	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AR—polycystic ovary syndrome	0.000146	0.000293	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SRD5A1—polycystic ovary syndrome	0.000144	0.00029	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000143	0.000288	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000143	0.000288	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000141	0.000284	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—STAR—polycystic ovary syndrome	0.000138	0.000277	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000138	0.000277	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000138	0.000277	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NR3C1—polycystic ovary syndrome	0.000137	0.000275	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000136	0.000274	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NCOR1—polycystic ovary syndrome	0.000135	0.000272	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NCOR1—polycystic ovary syndrome	0.000133	0.000267	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00013	0.000262	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00013	0.000262	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00013	0.000261	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000128	0.000257	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000127	0.000256	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NCOR1—polycystic ovary syndrome	0.000127	0.000256	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NCOR1—polycystic ovary syndrome	0.000127	0.000256	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000127	0.000255	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NR3C1—polycystic ovary syndrome	0.000125	0.000252	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000123	0.000248	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NR3C1—polycystic ovary syndrome	0.000123	0.000247	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HMMR—polycystic ovary syndrome	0.000123	0.000247	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000123	0.000247	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PPARG—polycystic ovary syndrome	0.000122	0.000246	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PPARG—polycystic ovary syndrome	0.000122	0.000246	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—POMC—polycystic ovary syndrome	0.00012	0.000242	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—POMC—polycystic ovary syndrome	0.00012	0.000242	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—INS—polycystic ovary syndrome	0.00012	0.000241	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—INS—polycystic ovary syndrome	0.00012	0.000241	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NR3C1—polycystic ovary syndrome	0.000118	0.000237	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NR3C1—polycystic ovary syndrome	0.000118	0.000237	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HSD3B1—polycystic ovary syndrome	0.000117	0.000236	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IL6—polycystic ovary syndrome	0.000116	0.000233	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000116	0.000233	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000116	0.000232	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000115	0.000232	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000113	0.000228	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—YAP1—polycystic ovary syndrome	0.000112	0.000225	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000112	0.000224	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00011	0.000221	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000109	0.00022	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000108	0.000217	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—LHB—polycystic ovary syndrome	0.000107	0.000215	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—LEP—polycystic ovary syndrome	0.000107	0.000215	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PPARG—polycystic ovary syndrome	0.000106	0.000213	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HSD3B2—polycystic ovary syndrome	0.000104	0.00021	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000103	0.000208	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000101	0.000203	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000101	0.000202	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	9.98e-05	0.000201	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	9.88e-05	0.000199	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	9.87e-05	0.000199	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—TNRC6B—polycystic ovary syndrome	9.86e-05	0.000198	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PGR—polycystic ovary syndrome	9.76e-05	0.000196	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PPARG—polycystic ovary syndrome	9.7e-05	0.000195	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—SERPINE1—polycystic ovary syndrome	9.56e-05	0.000192	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—polycystic ovary syndrome	9.52e-05	0.000191	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SULT2A1—polycystic ovary syndrome	9.31e-05	0.000187	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—polycystic ovary syndrome	9.3e-05	0.000187	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	9.19e-05	0.000185	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	9.19e-05	0.000185	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	9.12e-05	0.000183	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—polycystic ovary syndrome	9.12e-05	0.000183	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—polycystic ovary syndrome	9.12e-05	0.000183	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—INS—polycystic ovary syndrome	9.12e-05	0.000183	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—RRM2—polycystic ovary syndrome	9.02e-05	0.000181	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	9e-05	0.000181	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	8.9e-05	0.000179	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT2—polycystic ovary syndrome	8.81e-05	0.000177	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—SERPINE1—polycystic ovary syndrome	8.74e-05	0.000176	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—YAP1—polycystic ovary syndrome	8.69e-05	0.000175	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—SERPINE1—polycystic ovary syndrome	8.57e-05	0.000172	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	8.55e-05	0.000172	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	8.39e-05	0.000169	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NAMPT—polycystic ovary syndrome	8.35e-05	0.000168	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.3e-05	0.000167	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP11A1—polycystic ovary syndrome	8.25e-05	0.000166	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SERPINE1—polycystic ovary syndrome	8.22e-05	0.000165	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SERPINE1—polycystic ovary syndrome	8.22e-05	0.000165	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.19e-05	0.000165	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	8.02e-05	0.000161	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKR1C3—polycystic ovary syndrome	7.79e-05	0.000157	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP17A1—polycystic ovary syndrome	7.67e-05	0.000154	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	7.66e-05	0.000154	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AR—polycystic ovary syndrome	7.59e-05	0.000153	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	7.54e-05	0.000152	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	7.48e-05	0.00015	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	7.34e-05	0.000148	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	7.34e-05	0.000148	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	7.27e-05	0.000146	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	7.27e-05	0.000146	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	7.25e-05	0.000146	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	6.82e-05	0.000137	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	6.8e-05	0.000137	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	6.67e-05	0.000134	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NCOR1—polycystic ovary syndrome	6.63e-05	0.000133	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TH—polycystic ovary syndrome	6.63e-05	0.000133	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	6.58e-05	0.000132	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	6.48e-05	0.00013	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC2A4—polycystic ovary syndrome	6.45e-05	0.00013	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	6.23e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NR3C1—polycystic ovary syndrome	6.14e-05	0.000123	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	6.09e-05	0.000122	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP19A1—polycystic ovary syndrome	6.07e-05	0.000122	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	6.02e-05	0.000121	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	5.91e-05	0.000119	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	5.8e-05	0.000117	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	5.8e-05	0.000117	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	5.77e-05	0.000116	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—polycystic ovary syndrome	5.76e-05	0.000116	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	5.58e-05	0.000112	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—STAR—polycystic ovary syndrome	5.51e-05	0.000111	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.51e-05	0.000111	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	5.49e-05	0.00011	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GNAS—polycystic ovary syndrome	5.42e-05	0.000109	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NCOR1—polycystic ovary syndrome	5.16e-05	0.000104	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	4.92e-05	9.9e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	4.91e-05	9.87e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1A1—polycystic ovary syndrome	4.89e-05	9.83e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	4.86e-05	9.78e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—polycystic ovary syndrome	4.75e-05	9.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	4.68e-05	9.42e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.62e-05	9.29e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	4.61e-05	9.27e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—MTHFR—polycystic ovary syndrome	4.56e-05	9.17e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	4.4e-05	8.84e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.35e-05	8.74e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SERPINE1—polycystic ovary syndrome	4.28e-05	8.61e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LHB—polycystic ovary syndrome	4.27e-05	8.59e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	4.17e-05	8.39e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	4.04e-05	8.13e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—polycystic ovary syndrome	3.98e-05	8.01e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	3.92e-05	7.88e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	3.74e-05	7.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	3.72e-05	7.48e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—polycystic ovary syndrome	3.7e-05	7.43e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.7e-05	7.43e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—POMC—polycystic ovary syndrome	3.65e-05	7.33e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—INS—polycystic ovary syndrome	3.63e-05	7.29e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	3.6e-05	7.24e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.5e-05	7.04e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	3.47e-05	6.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	3.41e-05	6.86e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	3.34e-05	6.71e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	3.33e-05	6.7e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	3.3e-05	6.63e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	3.23e-05	6.49e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	3.11e-05	6.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	3.06e-05	6.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	2.97e-05	5.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	2.88e-05	5.78e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	2.77e-05	5.58e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	2.66e-05	5.36e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TH—polycystic ovary syndrome	2.65e-05	5.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.65e-05	5.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	2.63e-05	5.29e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.61e-05	5.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	2.58e-05	5.19e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	2.48e-05	5e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	2.45e-05	4.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	2.42e-05	4.88e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.16e-05	4.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TH—polycystic ovary syndrome	2.12e-05	4.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.06e-05	4.15e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.06e-05	4.14e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.95e-05	3.93e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.94e-05	3.89e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.82e-05	3.66e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.73e-05	3.47e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.65e-05	3.31e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.56e-05	3.14e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.48e-05	2.97e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.46e-05	2.93e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.45e-05	2.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.45e-05	2.91e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.18e-05	2.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.16e-05	2.34e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.16e-05	2.33e-05	CbGpPWpGaD
